Close Menu

genome analysis

The widely dispersed health system is integrating the Congenica platform into its clinical and research workflows to uncover genetic bases for rare conditions.

The Bruker-backed startup will make technology whose data could be complementary to both NGS-based Hi-C assays and spatial transcriptomics methods.

Fresh off a name change, the company last week introduced a monitoring platform for new SARS-CoV-2 variants that alerts diagnostic test makers to potential problems.

A Dutch province has awarded an unspecified sum to the Netherlands-based firms to combine their technologies for TCR and BCR repertoire sequencing and analysis.

In two recent papers, the UK startup demonstrated the integration of polygenic risk scoring into primary care screening and workflows.

The arrangement will allow Congenica to bring its clinical decision support platform to France for the first time.

The British genome analysis company will use the proceeds to continue its growth in the field of genomics-driven preventive care.

The firm posted total software-related revenues of $18.6 million, up 1 percent from $18.4 million in Q4 2019.

Genomenon will integrate its AI-driven Mastermind search engine into the BC|Genome and BC|Insight platforms. 

The Israeli bioinformatics firm is also mulling an expansion into human genetics.


The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.